JP2023539136A5 - - Google Patents

Info

Publication number
JP2023539136A5
JP2023539136A5 JP2023512161A JP2023512161A JP2023539136A5 JP 2023539136 A5 JP2023539136 A5 JP 2023539136A5 JP 2023512161 A JP2023512161 A JP 2023512161A JP 2023512161 A JP2023512161 A JP 2023512161A JP 2023539136 A5 JP2023539136 A5 JP 2023539136A5
Authority
JP
Japan
Prior art keywords
phenyl
methyl
pyridine
pyrrolo
methylsulfonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023512161A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023539136A (ja
JP7868034B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/046475 external-priority patent/WO2022040293A1/en
Publication of JP2023539136A publication Critical patent/JP2023539136A/ja
Publication of JP2023539136A5 publication Critical patent/JP2023539136A5/ja
Application granted granted Critical
Publication of JP7868034B2 publication Critical patent/JP7868034B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023512161A 2020-08-19 2021-08-18 Ｔｌｒ９阻害剤として有用な置換ヘテロアリール化合物 Active JP7868034B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063067389P 2020-08-19 2020-08-19
US63/067,389 2020-08-19
PCT/US2021/046475 WO2022040293A1 (en) 2020-08-19 2021-08-18 Substituted heteroaryl compounds useful as inhibitors of tlr9

Publications (3)

Publication Number Publication Date
JP2023539136A JP2023539136A (ja) 2023-09-13
JP2023539136A5 true JP2023539136A5 (enExample) 2024-08-26
JP7868034B2 JP7868034B2 (ja) 2026-06-01

Family

ID=77726550

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023512161A Active JP7868034B2 (ja) 2020-08-19 2021-08-18 Ｔｌｒ９阻害剤として有用な置換ヘテロアリール化合物

Country Status (17)

Country Link
US (1) US20230322770A1 (enExample)
EP (1) EP4200015B1 (enExample)
JP (1) JP7868034B2 (enExample)
KR (1) KR20230052930A (enExample)
CN (1) CN115956077A (enExample)
AR (1) AR123284A1 (enExample)
AU (1) AU2021328362A1 (enExample)
BR (1) BR112023002662A2 (enExample)
CA (1) CA3189816A1 (enExample)
CL (1) CL2023000428A1 (enExample)
CO (1) CO2023001670A2 (enExample)
ES (1) ES3070309T3 (enExample)
IL (1) IL300696A (enExample)
MX (1) MX2023001883A (enExample)
PE (1) PE20231318A1 (enExample)
TW (1) TW202227431A (enExample)
WO (1) WO2022040293A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4267560A1 (en) * 2020-12-22 2023-11-01 Gilead Sciences, Inc. 6-substituted indole compounds
EP4267559A1 (en) * 2020-12-22 2023-11-01 Gilead Sciences, Inc. Substituted indole compounds
US11661431B2 (en) 2021-04-16 2023-05-30 Gilead Sciences, Inc. Thienopyrrole compounds
TW202440078A (zh) 2021-09-10 2024-10-16 美商基利科學股份有限公司 噻吩并吡咯化合物
MX2024009441A (es) * 2022-02-18 2024-08-14 Bristol Myers Squibb Co Compuestos de imidazopiridinilo sustituidos utiles como inhibidores del receptor tipo toll 9 (tlr9).
WO2024102886A1 (en) * 2022-11-10 2024-05-16 Bristol-Myers Squibb Company Substituted benzimidazole compounds useful as inhibitors of tlr9
CN120152957A (zh) * 2022-11-10 2025-06-13 百时美施贵宝公司 用作tlr9抑制剂的经取代的喹诺酮

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130158049A1 (en) * 2011-12-20 2013-06-20 Hoffmann-La Roche Inc. 7-azaindole inhibitors of crac
US9643967B2 (en) 2013-12-13 2017-05-09 Takeda Pharmaceutical Company Limited Pyrrolo[3,2-c]pyridine derivatives as TLR inhibitors
AR103232A1 (es) * 2014-12-22 2017-04-26 Bristol Myers Squibb Co ANTAGONISTAS DE TGFbR
MX2020006168A (es) * 2017-12-18 2020-08-13 Bristol Myers Squibb Co Compuestos de 4-azaindol.
EP3728253B1 (en) * 2017-12-19 2024-03-27 Bristol-Myers Squibb Company 6-azaindole compounds
KR102730859B1 (ko) * 2017-12-20 2024-11-15 브리스톨-마이어스 스큅 컴퍼니 아릴 및 헤테로아릴 치환된 인돌 화합물

Similar Documents

Publication Publication Date Title
JP2023538608A5 (enExample)
RU2610262C2 (ru) ХИНОЛИНКАРБОКСАМИДНЫЕ И ХИНОЛИНКАРБОНИТРИЛЬНЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ mGLuR2-НЕГАТИВНЫХ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ, КОМПОЗИЦИИ И ИХ ПРИМЕНЕНИЕ
JP4814783B2 (ja) ピラゾロピリジン誘導体
JP2022531801A5 (enExample)
RU2481333C2 (ru) Производные 1,1,1-трифтор-2-гидрокси-3-фенилпропана
JP2022552324A5 (enExample)
JP2012525395A5 (enExample)
RU2018112237A (ru) Новые бициклические соединения в качестве дуальных ингибиторов atx/ca
EA032609B1 (ru) Соединения аминопиримидинила в качестве ингибиторов jak
IL274816B1 (en) The heteroaryl compounds are substituted with sulfone-pyridine alkyl amides
CN104725356B (zh) 氮杂环衍生物及其在药物中的应用
JP2013539777A5 (enExample)
RU2016102137A (ru) Первичные карбоксамиды в качестве ингибиторов bik
HRP20192323T1 (hr) Novi derivati dihidrokinolin-2-ona
RU2014120374A (ru) Имидазопиридазины
JP2023021316A (ja) ピリジンアミン－ピリドンおよびピリミジンアミン－ピリドン化合物
JP2021523177A5 (enExample)
JP2020503302A5 (enExample)
IL300696A (en) ALTERNATIVE HETEROARYL COMPOUNDS ARE USEFUL AS TLR9 INHIBITORS
JP2022534434A5 (enExample)
JP2011519891A5 (enExample)
JP2022505707A5 (enExample)
JP2021501183A5 (enExample)
JP2023538393A5 (enExample)
JP2023520647A5 (enExample)